128 related articles for article (PubMed ID: 37649540)
1. Urinary and serum levels of high mobility group box 1.
Nakamura T; Yoshida A; Hatanaka D; Kusakari M; Takahashi H; Katsuragi S; Yamada S; Kamohara T
Pract Lab Med; 2023 Aug; 36():e00327. PubMed ID: 37649540
[TBL] [Abstract][Full Text] [Related]
2. Elevation of high-mobility group box 1 concentration in asphyxiated neonates.
Okazaki K; Kondo M; Kato M; Kakinuma R; Nishida A; Noda M; Kimura H
Neonatology; 2008; 94(2):105-9. PubMed ID: 18277058
[TBL] [Abstract][Full Text] [Related]
3. Multicenter study for brain/body hypothermia for hypoxic-ischemic encephalopathy: Changes in HMGB-1.
Nakamura T; Asanuma H; Kusuda S; Imai K; Hosono S; Kato R; Suzuki S; Yokoi K; Kokubo M; Yamada S; Kamohara T
Pediatr Int; 2017 Oct; 59(10):1074-1079. PubMed ID: 28741799
[TBL] [Abstract][Full Text] [Related]
4. Correlation analysis of NT-proBNP (N-terminal probrain natriuretic peptide), 25-Hydroxyvitamin D, HMGB1(High-mobility group box 1), ACTA (endogenous activin A), blood glucose level, and electrolyte level with developmental quotient scores in neonates with hypoxic-ischemic encephalopathy.
Liu G; Cheng S; Wan L; Li Y; Zhao Q; Liu J; Jiang X
BMC Pediatr; 2022 Dec; 22(1):739. PubMed ID: 36577981
[TBL] [Abstract][Full Text] [Related]
5. Urinary high-mobility group box-1 associates specifically with lupus nephritis class V.
Jog NR; Blanco I; Lee I; Putterman C; Caricchio R
Lupus; 2016 Dec; 25(14):1551-1557. PubMed ID: 27075010
[TBL] [Abstract][Full Text] [Related]
6. Association of High Mobility Group Box Chromosomal Protein 1 and Receptor for Advanced Glycation End Products Serum Concentrations With Extraglandular Involvement and Disease Activity in Sjögren's Syndrome.
Kanne AM; Jülich M; Mahmutovic A; Tröster I; Sehnert B; Urbonaviciute V; Voll RE; Kollert F
Arthritis Care Res (Hoboken); 2018 Jun; 70(6):944-948. PubMed ID: 28941024
[TBL] [Abstract][Full Text] [Related]
7. Decreased Serum Levels of High Mobility Group Box 1 (HMGB-1) after Graft Replacement or Stenting of Abdominal Aortic Aneurysm.
Ousaka D; Fujii Y; Oozawa S; Nishibori M; Kuroko Y; Masuda Z; Sano S
Ann Vasc Surg; 2017 May; 41():265-270. PubMed ID: 27908811
[TBL] [Abstract][Full Text] [Related]
8. Increased level of high mobility group box 1 in the serum and skin in patients with generalized pustular psoriasis.
Watanabe T; Yamaguchi Y; Watanabe Y; Takamura N; Aihara M
J Dermatol; 2020 Sep; 47(9):1033-1036. PubMed ID: 32613742
[TBL] [Abstract][Full Text] [Related]
9. Impact of perioperative high mobility group box chromosomal protein 1 expression on long-term outcomes in patients with esophageal squamous cell carcinoma.
Tsujimoto H; Horiguchi H; Takahata R; Ono S; Yaguchi Y; Nomura S; Ito N; Harada M; Nagata H; Ishibashi Y; Kouzu K; Tsuchiya S; Itazaki Y; Fujishima S; Kishi Y; Ueno H
J Gastroenterol Hepatol; 2020 May; 35(5):788-794. PubMed ID: 31498489
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the expression of HMGB-1, CXCL16, miRNA-30a, and TGF-β1 in primary nephritic syndrome patients and its significance.
Wang WJ; Qu XQ; Yu XM; Lv W; Yu HY
Genet Mol Res; 2015 Aug; 14(3):9841-8. PubMed ID: 26345917
[TBL] [Abstract][Full Text] [Related]
11. High mobility group box protein-1 correlates with microinflammatory state and nutritional status in continuous ambulatory peritoneal dialysis patients.
Zhu N; Yuan W; Zhou Y; Liu J; Bao J; Hao J; Miao W
J Artif Organs; 2011 Jun; 14(2):125-32. PubMed ID: 21442152
[TBL] [Abstract][Full Text] [Related]
12. Association of circulating level of high mobility group box 1 with disease activity in antineutrophil cytoplasmic autoantibody-associated vasculitis.
Wang C; Gou SJ; Chang DY; Yu F; Zhao MH; Chen M
Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1828-34. PubMed ID: 24591411
[TBL] [Abstract][Full Text] [Related]
13. Study of Cord Blood Erythropoietin, Leptin and Adiponectin Levels in Neonates with Hypoxic Ischemic Encephalopathy.
Hagag AA; El Frargy MS; Abd El-Latif AE
Endocr Metab Immune Disord Drug Targets; 2020; 20(2):213-220. PubMed ID: 31345155
[TBL] [Abstract][Full Text] [Related]
14. The expression changes and correlation analysis of high mobility group box-1 and tissue factor in the serum of rats with sepsis.
Chen F; Jiang Y; Liu SL; Zou LH; Cao Y; Zhu YM
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1634-1640. PubMed ID: 30840287
[TBL] [Abstract][Full Text] [Related]
15. High-mobility group box-1 release into fetal circulation from umbilical cord tissue and amniotic epithelium in fetal ischemia.
Nakamura T; Yoshioka T; Yamada S; Miyasho T; Sakakibara N; Hatanaka D
Pediatr Int; 2016 Jul; 58(7):631-4. PubMed ID: 27097754
[TBL] [Abstract][Full Text] [Related]
16. Analysis of HMGB-1 level before and after providing atorvastatin standard therapy in coronary artery disease patients with type-2 diabetes mellitus compared to without type-2 diabetes mellitus.
Handayani W; Suharjono ; Yogiarto M
J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):439-446. PubMed ID: 34214372
[TBL] [Abstract][Full Text] [Related]
17. Postoperative serum concentrations of high mobility group box chromosomal protein-1 correlates to the duration of SIRS and pulmonary dysfunction following gastrointestinal surgery.
Takahata R; Ono S; Tsujimoto H; Hiraki S; Kimura A; Kinoshita M; Miyazaki H; Saitoh D; Hase K
J Surg Res; 2011 Sep; 170(1):e135-40. PubMed ID: 21696758
[TBL] [Abstract][Full Text] [Related]
18. A cross-sectional study of vitreous and serum high mobility group box-1 levels in proliferative diabetic retinopathy.
Shen Y; Cao H; Chen F; Suo Y; Wang N; Xu X
Acta Ophthalmol; 2020 Mar; 98(2):e212-e216. PubMed ID: 31421026
[TBL] [Abstract][Full Text] [Related]
19. [Expression of Serum HMGB-1 in Patients with Secondary Hemo-phagocytic Lymphohistiocytosis and Its Clinical Significance].
Wang DJ; Wang JJ; Song M; Gao X; Duan LM; Tian T; Qiu HX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):878-83. PubMed ID: 27342526
[TBL] [Abstract][Full Text] [Related]
20. Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients.
Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Ueda Y; Suzuki T; Yamada S; Takeuchi M; Fukami K; Ueda S; Adachi H; Matsui T; Okuda S; Yamagishi S
Metabolism; 2009 Nov; 58(11):1624-8. PubMed ID: 19604520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
